Search Results - "ZILEMBO, N" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out

by Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L.M., De Simone, I., Colombo, M.P., Sica, A., Torri, V., Garassino, M.C.
Published in Cancer treatment reviews (01.05.2019)

Get full text

Journal Article

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

by Ceresoli, G L, Zucali, P A, Mencoboni, M, Botta, M, Grossi, F, Cortinovis, D, Zilembo, N, Ripa, C, Tiseo, M, Favaretto, A G, Soto-Parra, H, De Vincenzo, F, Bruzzone, A, Lorenzi, E, Gianoncelli, L, Ercoli, B, Giordano, L, Santoro, A
Published in British journal of cancer (06.08.2013)

Get full text

Journal Article

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

by Procopio, G, Verzoni, E, Bracarda, S, Ricci, S, Sacco, C, Ridolfi, L, Porta, C, Miceli, R, Zilembo, N, Bajetta, E
Published in British journal of cancer (12.04.2011)

Get full text

Journal Article

Targeted therapy-induced diarrhea: A review of the literature

Targeted therapy-induced diarrhea: A review of the literature

by Pessi, M.A, Zilembo, N, Haspinger, E.R, Molino, L, Di Cosimo, S, Garassino, M, Ripamonti, C.I
Published in Critical reviews in oncology/hematology (01.05.2014)

Get full text

Journal Article

Effects of antibiotic use during immunotherapy in metastatic non-small cell lung cancer

Effects of antibiotic use during immunotherapy in metastatic non-small cell lung cancer

by Galli, G., Poggi, M., Fucà, G., Imbimbo, M., Proto, C., Signorelli, D., Vitali, M., Zilembo, N., Ganzinelli, M., de Braud, F., Garassino, M.C., Lo Russo, G.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

Characterization of patients with metastatic non-small cell lung cancer obtaining long term benefit from immunotherapy

Characterization of patients with metastatic non-small cell lung cancer obtaining long term benefit from immunotherapy

by Galli, G., Proto, C., Signorelli, D., Imbimbo, M., Ferrara, R., Prelaj, A., De Toma, A., Randon, G., Trevisan, B., Ganzinelli, M., Zilembo, N., Garassino, M.C., Lo Russo, G.
Published in Annals of oncology (01.04.2019)

Get full text

Journal Article

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial

by PROCOPIO, G, VERZONI, E, BRACARDA, S, RICCI, S, SACCO, C, RIDOLFI, L, PORTA, C, MICELI, R, ZILEMBO, N, BAJETTA, E
Published in Annals of oncology (01.12.2013)

Get full text

Journal Article

EPSILoN score: Validation cohort of a prognostic score in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

EPSILoN score: Validation cohort of a prognostic score in advanced non-small cell lung cancer (aNSCLC) patients treated with immunotherapy

by Prelaj, A., Lo Russo, G., Signorelli, D., Ferrara, R., Imbimbo, M., Galli, G., De Toma, A., Randon, G., Brambilla, M., Trevisan, B., Ganzinelli, M., Zilembo, N., De Braud, F., Garassino, M.C., Proto, C.
Published in Annals of oncology (01.04.2019)

Get full text

Journal Article

Basal lymphopenia as a potential predictor of benefit from immunotherapy in metastatic non-small cell lung cancer

Basal lymphopenia as a potential predictor of benefit from immunotherapy in metastatic non-small cell lung cancer

by Galli, G., Poggi, M., Fucà, G., Lo Russo, G., Proto, C., Signorelli, D., Vitali, M., Ganzinelli, M., Zilembo, N., de Braud, F., Garassino, M.C., Imbimbo, M.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

Impact of early steroids use on clinical outcomes of patients with advanced NSCLC treated with immune checkpoint inhibitors

Impact of early steroids use on clinical outcomes of patients with advanced NSCLC treated with immune checkpoint inhibitors

by Fucà, G., Poggi, M., Galli, G., Imbimbo, M., Lo Russo, G., Signorelli, D., Vitali, M., Ganzinelli, M., Zilembo, N., de Braud, F., Garassino, M.C., Proto, C.
Published in Annals of oncology (01.10.2018)

Get full text

Journal Article

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice

by Barni, S., Lorusso, V., Giordano, M., Sogno, G., Gamucci, T., Santoro, A., Passalacqua, R., Iaffaioli, V., Zilembo, N., Mencoboni, M., Roselli, M., Pappagallo, G., Pronzato, P.
Published in Medical oncology (Northwood, London, England) (2014)

Get full text

Journal Article

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study

Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study

by Bidoli, P, Zilembo, N, Cortinovis, D, Mariani, L, Isa, L, Aitini, E, Cullurà, D, Pari, F, Nova, P, Mancin, M, Formisano, B, Bajetta, E
Published in Annals of oncology (01.03.2007)

Get full text

Journal Article

Uracil ftorafur leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

Uracil ftorafur leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study

by BAJETTA, E, DI BARTOLOMEO, M, JACOBELLI, S, RECALDIN, E, PINOTTI, G, IOP, A, BUZZONI, R, MARIANI, L, ZILEMBO, N, FERRARIO, E, LO VULLO, S, AITINI, E, ISA, L, BARONE, C
Published in British journal of cancer (12.02.2007)

Get full text

Journal Article

9014 POSTER DISCUSSION Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) -Preliminary Results

9014 POSTER DISCUSSION Randomized Phase II Trial of NGR-hTNF and Chemotherapy in Chemo-naive Patients With Non-small Cell Lung Cancer (NSCLC) -Preliminary Results

by Gregore, V, Zilembo, N, Grossi, F, Rossoni, G, Pietrantonio, F, Rijavec, E, Citterio, G, Platania, M, Lambiase, A, Bordignon, C
Published in European journal of cancer (1990) (2011)

Get full text

Journal Article

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole

by Martinetti, A, Bajetta, E, Ferrari, L, Zilembo, N, Seregni, E, Del Vecchio, M, Longarini, R, La Torre, I, Toffolatti, L, Paleari, D, Bombardieri, E
Published in Endocrine-related cancer (01.12.2004)

Get full text

Journal Article

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease

Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease

by Bajetta, E, Di Leo, A, Biganzoli, L, Mariani, L, Cappuzzo, F, Di Bartolomeo, M, Zilembo, N, Artale, S, Magnani, E, Celio, L, Buzzoni, R, Carnaghi, C
Published in Journal of clinical oncology (01.09.1996)

Get more information

Journal Article

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism

by Bajetta, E., Martinetti, A., Zilembo, N., Pozzi, P., La Torre, I., Ferrari, L., Seregni, E., Longarini, R., Salvucci, G., Bombardieri, E.
Published in Annals of oncology (01.07.2002)

Get full text

Journal Article

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients

by Bajetta, E, Zilembo, N, Dowsett, M, Guillevin, L, Di Leo, A, Celio, L, Martinetti, A, Marchianò, A, Pozzi, P, Stani, S, Bichisao, E
Published in European journal of cancer (1990) (01.02.1999)

Get full text

Journal Article

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors

by Bajetta, E., Zilembo, N., Bichisao, E., Martinetti, A., Buzzoni, R., Pozzi, P., Bidoli, P., Ferrari, L., Celio, L.
Published in Annals of oncology (01.08.2000)

Get full text

Journal Article

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer

by Bajetta, E., Stani, S. C., De Candis, D., Zaffaroni, N., Zilembo, N., Cortinovis, D., Aglione, S., Mariani, L., Formisano, B., Bidoli, P.
Published in Annals of oncology (01.02.2003)

Get full text

Journal Article

1
2
3
4
5
6
7
Next
[7]